LEXINGTON, Mass. -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA - News), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback